EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 26 april 2024. Database contains 4917 unique substances/entries.
Filter the list
|
268-626-9
|
68131-73-7
|
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
Details | |||
|
263-125-1
|
61790-33-8
|
Acute Tox. 4; Asp. Tox. 1; STOT RE 2; Skin Corr. 1B |
Details | |||
|
217-990-7
|
2032-59-9
|
Acute Tox. 3 |
Details | |||
|
672-776-4
|
348635-87-0
|
Carc. 2; Eye Irrit. 2 |
Details | |||
|
251-375-4
|
33089-61-1
|
Acute Tox. 4; STOT RE 2; Skin Sens. 1 |
Details | |||
|
200-521-5
|
61-82-5
|
Repr. 2; STOT RE 2 |
Details | |||
|
215-647-6
|
1336-21-6
|
Skin Corr. 1B |
Details | |||
|
231-635-3
|
7664-41-7
|
Flam. Gas 2; Press. Gas; Acute Tox. 3; Skin Corr. 1B |
Details | |||
|
640 AMMONIUM SALT; KSMIA; S-102; SMIA
|
405-990-1
|
97148-39-5
|
Flam. Sol. 1 |
Details | ||
|
700-242-3
|
62037-80-3
|
E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) |
Details | |||
|
441-050-7
|
223705-57-5
|
Skin Irrit. 2; Eye Dam. 1 |
Details | |||
|
215-676-4
|
1341-49-7
|
Acute Tox. 3; Skin Corr. 1B |
Details | |||
|
AIZEN SPILON BLACK TRH; AIZEN SPILON SCHWARZ TRH; THR-1; TRH
|
400-110-2
|
109125-51-1
|
Self-react. C |
Details | ||
|
235-183-8
|
12124-97-9
|
Repr. 1B; Lact.; STOT SE 3; STOT RE 1; Eye Irrit. 2 |
Details | |||
|
235-186-4
|
12125-02-9
|
Acute Tox. 4; Eye Irrit. 2 |
Details | |||
|
232-143-1
|
7789-09-5
|
Ox. Sol. 2; Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Acute Tox. 4; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) |
Details | ||
|
235-185-9
|
12125-01-8
|
Acute Tox. 3 |
Details | |||
|
221-470-5
|
3108-42-7
|
Carc. 2; Repr. 1B; Lact. |
R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d) |
Details | ||
|
232-235-1
|
7790-98-9
|
Expl. 1.1; Ox. Sol. 1 |
Details | |||
|
228-098-2
|
6130-43-4
|
R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e) HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
|
269-511-6
|
68259-08-5
|
VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |||
|
249-415-0
|
29081-56-9
|
Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact. |
Details | |||
|
232-989-1
|
9080-17-5
|
Skin Corr. 1B |
Details | |||
|
221-037-0
|
2980-64-5
|
Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
Details | |||
|
-
|
4149-60-4
|
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1 |
R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d) |
Details | ||
|
223-320-4
|
3825-26-1
|
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1 |
R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d) |
Details | ||
|
232-565-6
|
9000-90-2
|
Resp. Sens. 1 |
Details | |||
|
show/hide
Amylase, mixed with proteinase, Bacillus thuringiensis-fermented
EC / List no:
-
| CAS no:
68909-36-4
|
-
|
-
|
Resp. Sens. 1 |
Details | ||
|
-
|
-
|
P Parasites |
Details | |||
|
433-560-3
|
15375-21-0
|
Repr. 2 |
Details | |||
|
-
|
-
|
P Parasites |
Details | |||
|
-
|
-
|
P Parasites |
Details | |||
|
202-910-5
|
101-05-3
|
Eye Irrit. 2; Skin Irrit. 2 |
Details | |||
|
200-539-3
|
62-53-3
|
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1 |
Details | |||
|
204-371-1
|
120-12-7
|
PBT Persistent, Bioaccumulative and Toxic (article 57d) |
Details | |||
|
A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325°C to 365°C (617°F to 689°F). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.
|
295-274-3
|
91995-14-1
|
Carc. 1B |
Details | ||
|
A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330°C to 350°C (626°F to 662°F). It contains chiefly anthracene, carbazole and phenanthrene.
|
295-275-9
|
91995-15-2
|
Carc. 1B; Muta. 1B |
C Carcinogenic (article 57a) M Mutagen (article 57b) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |
|
A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350°C to 360°C (662°F to 680°F). It contains chiefly anthracene, carbazole and phenanthrene.
|
295-276-4
|
91995-16-3
|
Carc. 1B; Muta. 1B |
Details | ||
|
A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290°C to 340°C (554°F to 644°F). It contains chiefly trinuclear aromatics and their dihydro derivatives.
|
295-278-5
|
91995-17-4
|
Carc. 1B; Muta. 1B |
C Carcinogenic (article 57a) M Mutagen (article 57b) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |
|
The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.
|
292-603-2
|
90640-81-6
|
Carc. 1B; Muta. 1B |
C Carcinogenic (article 57a) M Mutagen (article 57b) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |
|
The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.
|
292-604-8
|
90640-82-7
|
Carc. 1B; Muta. 1B |
C Carcinogenic (article 57a) M Mutagen (article 57b) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |
|
A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300°C to 400°C (572°F to 752°F). Composed primarily of phenanthrene, anthracene and carbazole
|
292-602-7
|
90640-80-5
|
Carc. 1B |
C Carcinogenic (article 57a) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e) |
Details | |
|
201-549-0
|
84-65-1
|
Carc. 1B |
Details | |||
|
-
|
-
|
Acute Tox. 4 |
Details | |||
|
231-601-8
|
7647-18-9
|
Skin Corr. 1B |
Details | |||
|
233-047-2
|
10025-91-9
|
Skin Corr. 1B |
Details | |||
|
232-009-2
|
7783-56-4
|
Acute Tox. 3 |
Details | |||
|
215-175-0
|
1309-64-4
|
Carc. 2 |
Details | |||
|
201-706-3
|
86-88-4
|
Acute Tox. 2; Carc. 2 |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||